Literature DB >> 27239234

The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma?

Shan Chen1, Junbing Guo1, Chongjin Feng2, Zunfu Ke3, Leihui Chen1, Yunping Pan1.   

Abstract

OBJECTIVE: Recent studies have shown that the presence of systemic inflammation and platelet status correlate with poor survival in various cancers. The aim of this study was to evaluate the prognostic value of the preoperative platelet-lymphocyte ratio (PLR) and the neutrophil-lymphocyte ratio (NLR) in patients with oral squamous cell carcinoma (OSCC) undergoing surgery.
METHODS: In this study, 306 patients with OSCC who had surgery were enrolled. The optimal cutoff value of PLR and NLR was determined by receiver operating characteristic (ROC) curve analysis. The prognostic significance of both markers was determined by uni- and multivariate analysis.
RESULTS: The results showed that high NLR and PLR were classified using a cutoff value of 2.7 and 135, respectively, based on ROC curve analysis. Only PLR was associated with decreased disease-free survival [hazard ratio (HR) = 2.237; 95% confidence interval (CI): 1.401-3.571; p = 0.001] and overall survival [HR = 2.022; 95% CI: 1.266-3.228; p = 0.003] by both uni- and multivariate analysis.
CONCLUSION: The preoperative PLR is superior to NLR as an independent indicator in predicting disease-free survival and overall survival in patients who undergo oral cancer resection for OSCC.

Entities:  

Keywords:  neutrophil to lymphocyte ratio; oral squamous cell carcinoma; platelet to lymphocyte ratio; prognostic factor

Year:  2016        PMID: 27239234      PMCID: PMC4872254          DOI: 10.1177/1758834016638019

Source DB:  PubMed          Journal:  Ther Adv Med Oncol        ISSN: 1758-8340            Impact factor:   8.168


  38 in total

Review 1.  Global epidemiology of oral and oropharyngeal cancer.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

2.  Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.

Authors:  Mi Ran Jung; Young Kyu Park; Oh Jeong; Jang Won Seon; Seong Yeob Ryu; Dong Yi Kim; Young Jin Kim
Journal:  J Surg Oncol       Date:  2011-05-25       Impact factor: 3.454

3.  Thrombocytosis in patients with lung cancer.

Authors:  S E Silvis; N Turkbas; A Doscherholmen
Journal:  JAMA       Date:  1970-03-16       Impact factor: 56.272

4.  Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

Authors:  Jacques Bernier; Jay S Cooper; T F Pajak; M van Glabbeke; J Bourhis; Arlene Forastiere; Esat Mahmut Ozsahin; John R Jacobs; J Jassem; Kie-Kian Ang; J L Lefèbvre
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

5.  Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer.

Authors:  Hiroshi Sato; Yasuhiro Tsubosa; Tatsuyuki Kawano
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

6.  Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer.

Authors:  Viren Asher; Joanne Lee; Anni Innamaa; Anish Bali
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

7.  Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population.

Authors:  Constantine Gorelick; Vaagn Andikyan; Mendy Mack; Yi-Chun Lee; Ovadia Abulafia
Journal:  Int J Gynecol Cancer       Date:  2009-11       Impact factor: 3.437

8.  Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma.

Authors:  D Gomez; S Farid; H Z Malik; A L Young; G J Toogood; J P A Lodge; K R Prasad
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

9.  Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.

Authors:  Karl Egan; Darragh Crowley; Paul Smyth; Sharon O'Toole; Cathy Spillane; Cara Martin; Michael Gallagher; Aoife Canney; Lucy Norris; Niamh Conlon; Lynda McEvoy; Brendan Ffrench; Britta Stordal; Helen Keegan; Stephen Finn; Victoria McEneaney; Alex Laios; Jens Ducrée; Eimear Dunne; Leila Smith; Michael Berndt; Orla Sheils; Dermot Kenny; John O'Leary
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

10.  A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection.

Authors:  Farhan Rashid; Naseem Waraich; Imran Bhatti; Shopan Saha; Raheela N Khan; Javed Ahmed; Paul C Leeder; Mike Larvin; Syed Y Iftikhar
Journal:  World J Surg Oncol       Date:  2010-01-06       Impact factor: 2.754

View more
  16 in total

1.  Platelet to lymphocyte ratio and red cell distribution width as prognostic factors for survival and recurrence in patients with oral cancer.

Authors:  Manupol Tangthongkum; Sireethorn Tiyanuchit; Virat Kirtsreesakul; Pasawat Supanimitjaroenporn; Wattana Sinkitjaroenchai
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-02       Impact factor: 2.503

2.  The pre-treatment neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and red cell distribution width predict prognosis in patients with laryngeal carcinoma.

Authors:  Medine Kara; Sema Uysal; Uğur Altinişik; Sibel Cevizci; Oğuz Güçlü; Fevzi Sefa Dereköy
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-12       Impact factor: 2.503

Review 3.  Pre-treatment neutrophil-to-lymphocyte ratio is an independent prognostic factor in head and neck squamous cell carcinoma: Meta-analysis and trial sequential analysis.

Authors:  Pierluigi Mariani; Diana Russo; Marco Maisto; Giuseppe Troiano; Vito Carlo Alberto Caponio; Marco Annunziata; Luigi Laino
Journal:  J Oral Pathol Med       Date:  2021-12-09       Impact factor: 3.539

4.  Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study.

Authors:  Takumi Hasegawa; Tomoya Iga; Daisuke Takeda; Rika Amano; Izumi Saito; Yasumasa Kakei; Junya Kusumoto; Akira Kimoto; Akiko Sakakibara; Masaya Akashi
Journal:  BMC Cancer       Date:  2020-06-17       Impact factor: 4.430

5.  Prognostic and clinicopathological significance of neutrophil-to-lymphocyte ratio in patients with oral cancer.

Authors:  Yun Yang; Rongxun Liu; Feng Ren; Rui Guo; Pengfei Zhang
Journal:  Biosci Rep       Date:  2018-12-11       Impact factor: 3.840

6.  The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer.

Authors:  Liqun Wang; Di Liang; Xiaoli Xu; Jing Jin; Shumei Li; Guo Tian; Zhaoyu Gao; Congmin Liu; Yutong He
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

7.  Prognostic significance of pre-treatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in non-surgically treated uterine cervical carcinoma.

Authors:  Kohei Nakamura; Kentaro Nakayama; Nagisa Tatsumi; Toshiko Minamoto; Tomoka Ishibashi; Kaori Ohnishi; Hitomi Yamashita; Ruriko Ono; Hiroki Sasamori; Sultana Razia; Shanta Kamrunnahar; Masako Ishikawa; Satoru Kyo
Journal:  Mol Clin Oncol       Date:  2018-06-05

8.  Prognostic value of neutrophil-to-lymphocyte ratio in peripheral blood and pathological tissue in patients with esophageal squamous cell carcinoma.

Authors:  Quanquan Guo; Zhiying Shao; Dan Xu; Lili Fan; Huiru Xiong; Xin Ding; Chuanwen You; Longzhen Zhang
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

9.  Prognostic value of systemic inflammatory markers for oral cancer patients based on the 8th edition of AJCC staging system.

Authors:  Sanghoon Lee; Dong Wook Kim; Sunmo Kwon; Hyung Jun Kim; In-Ho Cha; Woong Nam
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

10.  Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy.

Authors:  Wangqiang Jia; Long Yuan; Hongyan Ni; Benling Xu; Peng Zhao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.